These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25689223)

  • 1. RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT Mice.
    Shimizu S; Ringpis GE; Marsden MD; Cortado RV; Wilhalme HM; Elashoff D; Zack JA; Chen IS; An DS
    Mol Ther Nucleic Acids; 2015 Feb; 4(2):e227. PubMed ID: 25689223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice.
    Ringpis GE; Shimizu S; Arokium H; Camba-Colón J; Carroll MV; Cortado R; Xie Y; Kim PY; Sahakyan A; Lowe EL; Narukawa M; Kandarian FN; Burke BP; Symonds GP; An DS; Chen IS; Kamata M
    PLoS One; 2012; 7(12):e53492. PubMed ID: 23300932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model.
    Shimizu S; Hong P; Arumugam B; Pokomo L; Boyer J; Koizumi N; Kittipongdaja P; Chen A; Bristol G; Galic Z; Zack JA; Yang O; Chen IS; Lee B; An DS
    Blood; 2010 Feb; 115(8):1534-44. PubMed ID: 20018916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector.
    Burke BP; Levin BR; Zhang J; Sahakyan A; Boyer J; Carroll MV; Colón JC; Keech N; Rezek V; Bristol G; Eggers E; Cortado R; Boyd MP; Impey H; Shimizu S; Lowe EL; Ringpis GE; Kim SG; Vatakis DN; Breton LR; Bartlett JS; Chen IS; Kitchen SG; An DS; Symonds GP
    Mol Ther Nucleic Acids; 2015 Apr; 4():e236. PubMed ID: 25872029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
    Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo selection of anti-HIV-1 gene-modified human hematopoietic stem/progenitor cells to enhance engraftment and HIV-1 inhibition.
    Guo Q; Zhang J; Parikh K; Brinkley A; Lin S; Zakarian C; Pernet O; Shimizu S; Khamaikawin W; Hacke K; Kasahara N; An DS
    Mol Ther; 2024 Feb; 32(2):384-394. PubMed ID: 38087779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.
    Myburgh R; Ivic S; Pepper MS; Gers-Huber G; Li D; Audigé A; Rochat MA; Jaquet V; Regenass S; Manz MG; Salmon P; Krause KH; Speck RF
    J Virol; 2015 Jul; 89(13):6761-72. PubMed ID: 25903342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4
    Xiao Q; Chen S; Wang Q; Liu Z; Liu S; Deng H; Hou W; Wu D; Xiong Y; Li J; Guo D
    Retrovirology; 2019 Jun; 16(1):15. PubMed ID: 31186067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor.
    Wolstein O; Boyd M; Millington M; Impey H; Boyer J; Howe A; Delebecque F; Cornetta K; Rothe M; Baum C; Nicolson T; Koldej R; Zhang J; Keech N; Camba Colón J; Breton L; Bartlett J; An DS; Chen IS; Burke B; Symonds GP
    Mol Ther Methods Clin Dev; 2014; 1():11. PubMed ID: 26015947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34+ cells in HIV-1 infection.
    Tsukamoto T
    AIDS; 2018 Aug; 32(13):1737-1747. PubMed ID: 29762163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector.
    Walker JE; Chen RX; McGee J; Nacey C; Pollard RB; Abedi M; Bauer G; Nolta JA; Anderson JS
    J Virol; 2012 May; 86(10):5719-29. PubMed ID: 22398281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivo.
    Sato K; Misawa N; Iwami S; Satou Y; Matsuoka M; Ishizaka Y; Ito M; Aihara K; An DS; Koyanagi Y
    PLoS Pathog; 2013; 9(12):e1003812. PubMed ID: 24339781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-Delivered Entry Inhibitors for HIV-1: CCR5 Downregulation and Blocking Virus/Membrane Fusion in Defending the Host Cell Population.
    Symonds G; Bartlett JS; Kiem HP; Tsie M; Breton L
    AIDS Patient Care STDS; 2016 Dec; 30(12):545-550. PubMed ID: 27905841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.
    Swan CH; Bühler B; Steinberger P; Tschan MP; Barbas CF; Torbett BE
    Gene Ther; 2006 Oct; 13(20):1480-92. PubMed ID: 16738691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling Anti-HIV-1 HSPC-Based Gene Therapy in Humanized Mice Previously Infected with HIV-1.
    Khamaikawin W; Shimizu S; Kamata M; Cortado R; Jung Y; Lam J; Wen J; Kim P; Xie Y; Kim S; Arokium H; Presson AP; Chen ISY; An DS
    Mol Ther Methods Clin Dev; 2018 Jun; 9():23-32. PubMed ID: 29322065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo.
    Glushakova S; Yi Y; Grivel JC; Singh A; Schols D; De Clercq E; Collman RG; Margolis L
    J Clin Invest; 1999 Sep; 104(5):R7-R11. PubMed ID: 10487781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective infection of CD4+ effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD/SCID/IL-2Rgammanull mice.
    Nie C; Sato K; Misawa N; Kitayama H; Fujino H; Hiramatsu H; Heike T; Nakahata T; Tanaka Y; Ito M; Koyanagi Y
    Virology; 2009 Nov; 394(1):64-72. PubMed ID: 19744686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 infection by a unique short hairpin RNA to chemokine receptor 5 delivered into macrophages through hematopoietic progenitor cell transduction.
    Liang M; Kamata M; Chen KN; Pariente N; An DS; Chen IS
    J Gene Med; 2010 Mar; 12(3):255-65. PubMed ID: 20186995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection.
    Yu S; Yao Y; Xiao H; Li J; Liu Q; Yang Y; Adah D; Lu J; Zhao S; Qin L; Chen X
    Hum Gene Ther; 2018 Jan; 29(1):51-67. PubMed ID: 28599597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector.
    Anderson J; Akkina R
    AIDS Res Ther; 2005 Jan; 2(1):1. PubMed ID: 15813990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.